Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
14 January 2017
Some of the biggest airports in the UK have been forced to cancel flights as snow and blizzard conditions sweep parts of the country.
13 January 2017
Stress could be as significant a risk factor for heart attacks and strokes as smoking, drinking and overeating, new research shows.
24 December 2016
Planned strikes by British Airways cabin crew on Christmas Day and Boxing Day have been suspended amid continuing industrial unrest ahead of the weekend break.
11 January 2017
A connection between diabetes and inflection in children could be a major breakthrough in developing a cure for type 1 diabetes, according to new research.
10 January 2017
A new trial aimed at tackling widespread loneliness among older people is successfully reducing isolation using community-based tactics, a report shows.
07 January 2017
People may be able to enjoy better brain health in later life by following a Mediterranean diet, research has suggested.
06 January 2017
Many Britons plan to cut down on the costs of their holidays in 2017, as part of their financial resolutions for the New Year.
05 January 2017
Holidaymakers have been encouraged to make the most of the fact 2017 boasts a pair of bank holiday weekends just two weeks apart.
04 January 2017
Holidaymakers are increasingly turning their attentions to trips which are all-inclusive, new research has suggested.
31 December 2016
Budget airline Norwegian has said it will launch ultra-low cost flights for as little at £56 to New York as it ramps up the pressure on its rivals.
30 December 2016
Some of the most famous artists in history may have left subtle clues to brain disease in their paintings, new research suggests.
29 December 2016
A positive outlook for the UK travel industry is being tempered by uncertainty over the economy, according to a new report.